Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global . | March 29, 2022
Pioneers in observing single molecules in living cells Funds will be used to build a product portfolio that harnesses the company's innovative technology to unlock new possibilities in therapeutic
Stilla Technologies, the multiplex digital PCR company, today announced it has raised €31.3 million in the form of €11.3 million of convertible bonds and €20 million in loan financing. In addition